Show simple item record

dc.contributor.authorCooksley, Timothy J
dc.contributor.authorKnight, Thomas
dc.contributor.authorGupta, Avinash
dc.contributor.authorHigham, Claire E
dc.contributor.authorLorigan, Paul C
dc.contributor.authorAdam, Safwaan
dc.date.accessioned2020-08-10T08:09:20Z
dc.date.available2020-08-10T08:09:20Z
dc.date.issued2020en
dc.identifier.citationCooksley T, Knight T, Gupta A, Higham C, Lorigan P, Adam S. Emergency ambulatory outpatient management of immune-mediated hypophysitis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2020;28(9):3995-9.en
dc.identifier.pmid32564193en
dc.identifier.doi10.1007/s00520-020-05581-zen
dc.identifier.urihttp://hdl.handle.net/10541/623090
dc.description.abstractPurpose: Immune-mediated hypophysitis is an important toxicity related to immune checkpoint inhibitors (ICI). Optimal management is associated with improved outcomes. It represents a wide spectrum of clinical presentations, and a proportion may be suitable for emergency ambulatory management. Methods: Emergency ambulatory management of patients presenting with clinical features and findings consistent with ICI-induced hypophysitis was considered at a tertiary cancer/endocrinology hospital. Suitable patients were initially investigated and treated in accordance with the UK emergency management guidelines for ICI induced hypophysitis. After an initial observation period of 4 h, patients were discharged with oral hydrocortisone (20, 10, 10 mg). Results: An initial cohort of 4 patients with emergency presentations of ICI-induced hypophysitis has been managed in an ambulatory fashion in the first 3 months. There were no 30-day readmissions. Conclusion: Carefully selected emergency presentations with immune-mediated hypophysitis may be suitable for ambulatory management. Keywords: Ambulatory; Emergency oncology; Hypophysitis; Immune checkpoint inhibitors.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1007/s00520-020-05581-zen
dc.titleEmergency ambulatory outpatient management of immune-mediated hypophysitisen
dc.typeArticleen
dc.contributor.departmentDepartment of Acute Medicine and Critical Care, The Christie, Wilmslow Road, Manchester, UKen
dc.identifier.journalSupportive Care in Canceren
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record